Results 1 to 10 of about 247 (100)
Infodemiology of RSV in Italy (2017–2022): An Alternative Option for the Surveillance of Incident Cases in Pediatric Age? [PDF]
Children, 2022 The aim of this study was to evaluate whether or not online queries for Respiratory Syncytial Virus (RSV) retrieved by means of Google Trends™ and the Italian Wikipedia analysis program mirror the occurrence of influenza-like illnesses (ILI), as reported
Matteo Riccò +7 more
doaj +5 more sources
Infectious Disease Modelling, 2017 Background: Influenza pandemics emerge at irregular and unpredictable intervals to cause substantial health, economic and social burdens. Optimizing health-system response is vital to mitigating the consequences of future pandemics. Methods: We developed
Patrick Saunders-Hastings +3 more
doaj +4 more sources
The hospitalization burden of influenza: just the tip of the iceberg? [PDF]
Global & Regional Health Technology Assessment, 2018 Introduction: The codes used to report hospital admissions due to influenza viruses are likely to underestimate the real incidence of influenza-related cases.
Arianna Bertolani +2 more
doaj +2 more sources
Bollettino epidemiologico nazionale, 2023 The impact of influenza viruses and influenza vaccination coverage in Italy in the 2021-2022 season: the InfluNet integrated surveillance system and the introduced news Introduction In Italy, the InfluNet integrated influenza surveillance system, during the 2021-2022 season, in the middle of the SARS-CoV-2 pandemic, was adequately modified and ...
Bella, Antonino +11 more
openaire +1 more source
ARVI: rational pharmacotherapy from the standpoint of clinical pharmacology
Медицинский совет, 2016 More than 30 million cases of influenza and acute respiratory viral infections are registered in Russia every year. Therefore, the problem of adequate pharmacotherapy is turning into a real challenge.
N. B. Lazareva +2 more
doaj +1 more source
Pharmacological and non-pharmacological treatments for ARVI
Медицинский совет, 2015 ARVI is one of the most common diseases worldwide. Search for adequate treatment remains an urgent public healthcare problem globally. The main task is still an effective and safe relief of ARVI symptoms, for the purpose of which both pharmacological and
I. L. Lazarevich
doaj +1 more source
Медицинский совет, 2014 The article considers current issues of the pathogenesis of acute respiratory viral infections (ARVI); there is current data on the advantages and disadvantages of the main groups of drugs used in the pharmacotherapy of ARVI.
O. A. Mubarakshina
doaj +1 more source
Clinical pattern, diagnosis and treatment of flu and ARVI
Медицинский совет, 2015 Flu and ARVI are among the most dangerous infectious diseases recorded in Russia, both in terms of the financial burden and the damage they cause to the health of the population.
K. A. Aitov
doaj +1 more source
ARVI: rational pharmacotherapy
Медицинский совет, 2014 ARVI is the most common group of mass diseases and number one among infectious diseases. Adequate protection against influenza and ARVI can be achieved with the help of modern drugs that create a barrier on the way of the virus and increase the body's ...
N. I. Lapidus
doaj +1 more source
A COMPREHENSIVE APPROACH TO THE TREATMENT OF INFLUENZA AND ARVI
Медицинский совет, 2017 The past XX century and early XXI century are marked by a widespread increase in viral infections, regardless of the level of socio-economic development of the country.
L. V. Luss
doaj +1 more source